Personal information

Keywords

Cancer research, Bladder cancer, Circulating tumor DNA, Liquid biopsies, Tumor evolution, Tumor heterogeneity, Bioinformatics

Countries

Denmark

Activities

Collapse all

Employment (1)

Aarhus University Hospital: Aarhus, DK

2017-11-01 to present | Post doc (Department of Molecular Medicine)
Employment
Source: Self-asserted source
Emil Christensen

Education and qualifications (1)

Aarhus University Hospital: Aarhus, DK

2014-12-01 to 2018-03-15 | PhD (Department of Molecular Medicine)
Education
Source: Self-asserted source
Emil Christensen

Works (44)

Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

Clinical Cancer Research
2023-12-01 | Journal article
DOI: 10.1158/1078-0432.CCR-23-1860
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Data from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.c.6960625.v1
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Data from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.c.6960625
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710668.v1
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710668
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710665
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710665.v1
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Figure 3 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710662
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Figure 3 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710662.v1
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Figure 4 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710659
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Figure 4 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710659.v1
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Table 1 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710656
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Supplementary Table 1 from Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710656.v1
Contributors: Sia V. Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine G. Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up

2023-06-25 | Preprint
DOI: 10.1101/2023.06.20.23291650
Contributors: Sia Viborg Lindskrog; Karin Birkenkamp-Demtröder; Iver Nordentoft; George Laliotis; Philippe Lamy; Emil Christensen; Derrick Renner; Tine Ginnerup Andreasen; Naja Lange; Shruti Sharma et al.
Source: check_circle
Crossref

Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

Clinical Cancer Research
2023-04-14 | Journal article
DOI: 10.1158/1078-0432.CCR-22-3250
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Data from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.c.6533092.v2
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Data from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.c.6533092
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Figures S1-S13 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633010
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Figures S1-S13 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633010.v1
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633007.v1
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633007
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633004
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633004.v1
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Data from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.c.6533092.v1
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Figures S1-S13 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490092.v1
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Figures S1-S13 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490092
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490089.v1
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490089
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490086.v1
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490086
Contributors: Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy et al.
Source: check_circle
Crossref

Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis

Nature Communications
2022-04-04 | Journal article
DOI: 10.1038/s41467-022-29627-4
Contributors: Ann Taber; Emil Christensen; Philippe Lamy; Iver Nordentoft; Frederik Prip; Sia Viborg Lindskrog; Karin Birkenkamp-Demtröder; Trine Line Hauge Okholm; Michael Knudsen; Jakob Skou Pedersen et al.
Source: check_circle
Crossref

Elevated T-cell exhaustion and urinary tumor DNA levels are associated with BCG failure in patients with non-muscle invasive bladder cancer

2022-03-23 | Preprint
DOI: 10.1101/2022.03.23.22272806
Contributors: Trine Strandgaard; Sia Viborg Lindskrog; Iver Nordentoft; Emil Christensen; Karin Birkenkamp-Demtröder; Tine Ginnerup Andreasen; Philippe Lamy; Asbjørn Kjær; Daniel Ranti; Yuan-Sho Wang et al.
Source: check_circle
Crossref

Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy

Nature Communications
2021-08-10 | Journal article
DOI: 10.1038/s41467-021-24839-6
Contributors: Ann Taber; Emil Christensen; Philippe Lamy; Mads Agerbæk; Jørgen Bjerggaard Jensen; Lars Dyrskjøt
Source: check_circle
Crossref

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

Nature Communications
2021-04-16 | Journal article
DOI: 10.1038/s41467-021-22465-w
Contributors: Sia Viborg Lindskrog; Frederik Prip; Philippe Lamy; Ann Taber; Clarice S. Groeneveld; Karin Birkenkamp-Demtröder; Jørgen Bjerggaard Jensen; Trine Strandgaard; Iver Nordentoft; Emil Christensen et al.
Source: check_circle
Crossref

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis

Nature Communications
2020-09-25 | Journal article
DOI: 10.1038/s41467-020-18640-0
Contributors: Ann Taber; Emil Christensen; Philippe Lamy; Iver Nordentoft; Frederik Prip; Sia Viborg Lindskrog; Karin Birkenkamp-Demtröder; Trine Line Hauge Okholm; Michael Knudsen; Jakob Skou Pedersen et al.
Source: check_circle
Crossref

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Nature Reviews Urology
2020-05 | Journal article
DOI: 10.1038/s41585-020-0304-1
Contributors: Joshua J. Meeks; Hikmat Al-Ahmadie; Bishoy M. Faltas; John A. Taylor, III; Thomas W. Flaig; David J. DeGraff; Emil Christensen; Benjamin L. Woolbright; David J. McConkey; Lars Dyrskjøt
Source: check_circle
Crossref

Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.

Journal of clinical oncology
2019-05-06 | Journal article
DOI: 10.1200/jco.18.02052
PMID: 31059311
Source: Self-asserted source
Emil Christensen

Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis

European Urology
2018-04 | Journal article
DOI: 10.1016/j.eururo.2017.09.011
Part of ISSN: 0302-2838
Contributors: Karin Birkenkamp-Demtröder; Emil Christensen; Iver Nordentoft; Michael Knudsen; Ann Taber; Søren Høyer; Philippe Lamy; Mads Agerbæk; Jørgen Bjerggaard Jensen; Lars Dyrskjøt
Source: Self-asserted source
Emil Christensen via Crossref Metadata Search

Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients

Scientific Reports
2018-01 | Journal article
DOI: 10.1038/s41598-018-20282-8
Part of ISSN: 2045-2322
Contributors: Emil Christensen; Iver Nordentoft; Søren Vang; Karin Birkenkamp-Demtröder; Jørgen Bjerggaard Jensen; Mads Agerbæk; Jakob Skou Pedersen; Lars Dyrskjøt
Source: Self-asserted source
Emil Christensen via Crossref Metadata Search

Abstract 2752: Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder cancer

Cancer Research
2017-07-01 | Journal article
DOI: 10.1158/1538-7445.am2017-2752
Part of ISSN: 0008-5472
Contributors: Emil Christensen; Karin Birkenkamp-Demtröder; Iver Nordentoft; Søren Høyer; Kirstin Van Der Keur; Kim Van Kessel; Ellen Zwarthoff; Mads Agerbæk; Torben Falck Ørntoft; Jørgen Bjerggaard Jensen et al.
Source: Self-asserted source
Emil Christensen via Crossref Metadata Search

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer

European Urology
2017-06 | Journal article
DOI: 10.1016/j.eururo.2016.12.016
Part of ISSN: 0302-2838
Contributors: Emil Christensen; Karin Birkenkamp-Demtröder; Iver Nordentoft; Søren Høyer; Kirstin van der Keur; Kim van Kessel; Ellen Zwarthoff; Mads Agerbæk; Torben Falck Ørntoft; Jørgen Bjerggaard Jensen et al.
Source: Self-asserted source
Emil Christensen via Crossref Metadata Search

Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer

Scientific Reports
2017-03 | Journal article
DOI: 10.1038/s41598-017-00327-0
Part of ISSN: 2045-2322
Contributors: Anna Katharina Seitz; Lise Lotte Christensen; Emil Christensen; Kasper Faarkrog; Marie Stampe Ostenfeld; Jakob Hedegaard; Iver Nordentoft; Morten Muhlig Nielsen; Johan Palmfeldt; Michelle Thomson et al.
Source: Self-asserted source
Emil Christensen via Crossref Metadata Search

Prognostic impact of a 12-gene progression score in non-muscle invasive bladder cancer: A prospective multicenter validation study

European Urology Supplements
2017-03 | Journal article
DOI: 10.1016/s1569-9056(17)30444-x
Part of ISSN: 1569-9056
Contributors: L. Dyrskjøt; T. Reinert; F. Algaba; E. Christensen; D. Nieboer; G. Hermann; K. Morgensen; M. Marquez; U. Segersten; S. Hoyer et al.
Source: Self-asserted source
Emil Christensen via Crossref Metadata Search

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer

European Urology
2016-07 | Journal article
DOI: 10.1016/j.eururo.2016.01.007
Part of ISSN: 0302-2838
Contributors: Karin Birkenkamp-Demtröder; Iver Nordentoft; Emil Christensen; Søren Høyer; Thomas Reinert; Søren Vang; Michael Borre; Mads Agerbæk; Jørgen Bjerggaard Jensen; Torben F. Ørntoft et al.
Source: Self-asserted source
Emil Christensen via Crossref Metadata Search
How many people are using ORCID?